Skip to main content

Table 1 Demographic and clinical characteristics of cognitively normal participants by the categories of serum zinc

From: Serum zinc levels and in vivo beta-amyloid deposition in the human brain

Characteristic

Overall

Categorized zinc level

P

 

Low

Medium

High

 

N

241

70

80

91

 

Age, y

69.73 (8.00)

70.14 (7.13)

71.04 (8.41)

68.26 (8.11)

0.067a

Female, n (%)

114 (47.30)

36 (51.43)

39 (48.75)

39 (42.86)

0.531b

Education, y

11.61 (4.76)

11.00 (4.84)

11.39 (4.92)

12.27 (4.50)

0.212a

APOE4 positivity, n (%)

44 (18.26)

14 (20.00)

15 (18.75)

15 (16.48)

0.841b

VRS, %

17.57 (16.47)

16.90 (14.33)

18.54 (17.18)

17.22 (17.47)

0.806a

MMSE

26.82 (2.67)

26.34 (2.44)

26. 93 (3.29)

27.10 (2.18)

0.189a

BMI, kg/m2

24.18 (2.92)

24.29 (3.06)

24.00 (2.80)

24.25 (2.94)

0.793a

GDS score

4.93 (5.09)

5.04 (5.24)

5.63 (5.26)

4.22 (4.76)

0.192a

Annual income status

    

0.887c

  < MCL, n (%)

15 (6.22)

3 (4.29)

5 (6.25)

7 (7.69)

 

 ≥MCL, < 2 × MCL, n (%)

115 (47.72)

32 (45.71)

40 (50.00)

43 (47.25)

 

 ≥2 × MCL, n (%)

111 (46.06)

35 (50.00)

35 (43.75)

41 (45.05)

 

Zinc, μg/dL

86.85 (11.79)

73.36 (4.90)

85.04 (2.85)

98.80 (7.50)

< 0.001a

Albumin, g/dL

4.49 (0.25)

4.38 (0.23)

4.53 (0.21)

4.53 (0.27)

< 0.001a

Copper, μg/dL

102.32 (17.78)

100.73 (20.25)

101.91 (15.62)

103.91 (17.60)

0.515a

Calcium, mg/dL

9.45 (0.31)

9.35 (0.30)

9.46 (0.29)

9.50 (0.32)

0.010a

Iron, μg/dL

122.61 (40.75)

111.59 (41.13)

116.84 (38.35)

136.18 (39.13)

< 0.001a

Transferrin, mg/dL

271.15 (39.38)

262.74 (37.04)

271.26 (38.67)

277.51 (40.92)

0.061a

Ceruloplasmin, mg/dL

24.14 (5.08)

23.91 (5.78)

24.87 (4.41)

23.67 (5.04)

0.276a

Total cholesterol, mg/dL

183.57 (31.49)

181.50 (27.66)

180.75 (28.86)

187.64 (36.05)

0.293a

Nutritional deficiency

36 (14.94)

10 (14.29)

13 (16.25)

13 (14.29)

0.922b

Neuroimage biomarkers

     

 Cerebral Aβ deposition

     

  Aβ retention, SUVR

1.20 (0.23)

1.26 (0.34)

1.20 (0.21)

1.16 (0.12)

0.021a

 Cerebral tau deposition (n = 58)

     

  AV-1451, SUVR

1.34 (0.26)

1.36 (0.30)

1.29 (0.21)

1.38 (0.24)

0.575a

 AD-CM, SUVR

1.42 (0.12)

1.39 (0.13)

1.41 (0.12)

1.44 (0.12)

0.077a

 WMH volume, cm3

12.29 (11.68)

11.14 (10.13)

12.91 (12.37)

12.65 (12.25)

0.625a

  1. Abbreviations: MMSE Mini-Mental State Examination, APOE4 apolipoprotein E ε4 allele, VRS vascular risk score, BMI body mass index, GDS geriatric depression scale, MCL minimum cost of living, beta-amyloid, AD Alzheimer’s disease, AD-CM Alzheimer’s disease signature cerebral glucose metabolism, SUVR standardized uptake value ratio
  2. Data are expressed as mean (standard deviation), unless otherwise indicated
  3. aBy one-way analysis of variance
  4. bBy chi-square test
  5. cBy Fisher exact test